Reverse transcriptases and uses thereof

US12065645B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12065645-B2
Application numberUS-202318125661-A
CountryUS
Kind codeB2
Filing dateMar 23, 2023
Priority dateFeb 16, 2017
Publication dateAug 20, 2024
Grant dateAug 20, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Hybrid reverse transcriptases formed from portions of FLVRT and MLVRT are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A nucleic acid comprising a polynucleotide encoding a hybrid reverse transcriptase, the hybrid reverse transcriptase comprising a finger domain, a palm domain, a thumb domain, a connection domain and an RNase H domain, wherein (A) the hybrid reverse transcriptase comprises: (i) a portion of feline leukemia virus reverse transcriptase (FLVRT) comprising the finger domain and the palm domain, wherein the portion of the FLVRT is at least 95% identical to SEQ…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12065645B2 cover?
Hybrid reverse transcriptases formed from portions of FLVRT and MLVRT are provided.
Who is the assignee on this patent?
Bio Rad Laboratories Inc
What technology area does this patent fall under?
Primary CPC classification C12N15/1096. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).